Boston Scientific Corporation

48.22+0.2800+0.58%Vol 9.08M1Y Perf 11.83%
Mar 24th, 2023 16:00 DELAYED
BID47.50 ASK49.00
Open47.90 Previous Close47.94
Pre-Market- After-Market48.57
 - -  0.35 0.73%
Target Price
49.61 
Analyst Rating
Strong Buy 1.47
Potential %
2.88 
Finscreener Ranking
     40.16
Insiders Trans % 3/6/12 mo.
-100/-100/-96 
Value Ranking
     41.65
Insiders Value % 3/6/12 mo.
-100/-100/-96 
Growth Ranking
★★     43.98
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-96 
Income Ranking
 —    -
Price Range Ratio 52W %
92.98 
Earnings Rating
Sell
Market Cap69.31B 
Earnings Date
26th Apr 2023
Alpha-0.00 Standard Deviation0.07
Beta0.83 

Today's Price Range

47.5248.31

52W Range

34.9849.22

5 Year PE Ratio Range

-432.30493.00

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
0.56%
1 Month
2.57%
3 Months
4.69%
6 Months
23.96%
1 Year
11.83%
3 Years
61.16%
5 Years
83.35%
10 Years
558.74%

TickerPriceChg.Chg.%
BSX48.220.28000.58
AAPL160.251.32000.83
GOOG106.08-0.1850-0.17
MSFT280.572.91001.05
XOM103.530.12000.12
WFC36.23-0.3800-1.04
JNJ152.651.52001.01
FB196.640.99000.51
GE91.37-0.2200-0.24
JPM124.91-1.9300-1.52
 
ProfitabilityValueIndustryS&P 500US Markets
68.50
10.80
19.80
9.30
5.91
RevenueValueIndustryS&P 500US Markets
9.44B
6.59
4.98
5.85
Earnings HistoryEstimateReportedSurprise %
Q04 20220.470.45-4.26
Q03 20220.440.43-2.27
Q02 20220.420.444.76
Q01 20220.380.392.63
Q04 20210.440.452.27
Q03 20210.400.412.50
Q02 20210.370.408.11
Q01 20210.300.3723.33
Earnings Per EndEstimateRevision %Trend
12/2022 QR0.47-2.08Negative
12/2022 FY1.73-1.70Negative
3/2023 QR0.44-2.22Negative
12/2023 FY1.91-2.55Negative
Next Report Date26th Apr 2023
Estimated EPS Next Report0.44
Estimates Count11
EPS Growth Next 5 Years %10.30
Volume Overview
Volume9.08M
Shares Outstanding1.44M
Shares Float1.43B
Trades Count58.33K
Dollar Volume435.97M
Avg. Volume7.63M
Avg. Weekly Volume8.35M
Avg. Monthly Volume7.55M
Avg. Quarterly Volume7.00M

Boston Scientific Corporation (NYSE: BSX) stock closed at 48.22 per share at the end of the most recent trading day (a 0.58% change compared to the prior day closing price) with a volume of 9.08M shares and market capitalization of 69.31B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 38000 people. Boston Scientific Corporation CEO is Michael F. Mahoney.

The one-year performance of Boston Scientific Corporation stock is 11.83%, while year-to-date (YTD) performance is 4.21%. BSX stock has a five-year performance of 83.35%. Its 52-week range is between 34.98 and 49.22, which gives BSX stock a 52-week price range ratio of 92.98%

Boston Scientific Corporation currently has a PE ratio of 110.30, a price-to-book (PB) ratio of 3.76, a price-to-sale (PS) ratio of 6.92, a price to cashflow ratio of 55.70, a PEG ratio of 2.32, a ROA of 2.02%, a ROC of 3.66% and a ROE of 3.77%. The company’s profit margin is 5.91%, its EBITDA margin is 19.80%, and its revenue ttm is $9.44 Billion , which makes it $6.59 revenue per share.

Of the last four earnings reports from Boston Scientific Corporation, there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.44 for the next earnings report. Boston Scientific Corporation’s next earnings report date is 26th Apr 2023.

The consensus rating of Wall Street analysts for Boston Scientific Corporation is Strong Buy (1.47), with a target price of $49.61, which is +2.88% compared to the current price. The earnings rating for Boston Scientific Corporation stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Boston Scientific Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Boston Scientific Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 9.31, ATR14 : 0.84, CCI20 : 49.87, Chaikin Money Flow : 0.16, MACD : 0.38, Money Flow Index : 59.80, ROC : 2.84, RSI : 55.79, STOCH (14,3) : 66.89, STOCH RSI : 0.25, UO : 58.61, Williams %R : -33.11), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Boston Scientific Corporation in the last 12-months were: Arthur C. Butcher (Option Excercise at a value of $425 713), Arthur C. Butcher (Sold 47 538 shares of value $2 240 246 ), Daniel J. Brennan (Option Excercise at a value of $771 751), Daniel J. Brennan (Sold 113 182 shares of value $5 283 178 ), Eric Francis Yves Thepaut (Option Excercise at a value of $0), Eric Francis Yves Thepaut (Sold 35 628 shares of value $1 486 283 ), Ian T. Meredith (Sold 6 588 shares of value $287 764 ), Jeffrey B. Mirviss (Option Excercise at a value of $387 155), Jeffrey B. Mirviss (Sold 88 620 shares of value $4 095 675 ), Jodi Euerle Eddy (Sold 2 779 shares of value $125 055 ), John Bradley Sorenson (Option Excercise at a value of $0), Jonathan Monson (Option Excercise at a value of $0), Jonathan R. Monson (Option Excercise at a value of $64 450), Jonathan R. Monson (Sold 5 000 shares of value $233 315 ), Joseph M. Fitzgerald (Option Excercise at a value of $585 761), Joseph M. Fitzgerald (Sold 79 264 shares of value $3 787 234 ), Meghan Scanlon (Option Excercise at a value of $0), Michael F. Mahoney (Option Excercise at a value of $4 704 070), Michael F. Mahoney (Sold 503 310 shares of value $20 479 545 ), Nelda J. Connors (Sold 34 284 shares of value $1 478 183 ), Scott Olson (Sold 700 shares of value $31 185 ), Vance R. Brown (Option Excercise at a value of $0), Wendy Carruthers (Option Excercise at a value of $94 954), Wendy Carruthers (Sold 139 171 shares of value $5 789 872 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
11 (68.75 %)
11 (68.75 %)
12 (80.00 %)
Moderate Buy
2 (12.50 %)
2 (12.50 %)
1 (6.67 %)
Hold
3 (18.75 %)
3 (18.75 %)
2 (13.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.47
Strong Buy
1.47
Strong Buy
1.33

Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

CEO: Michael F. Mahoney

Telephone: +1 508 683-4000

Address: 300 Boston Scientific Way, Marlborough 01752-1234, MA, US

Number of employees: 38 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Bearish Bullish

60%40%

Bearish Bullish

61%39%

TipRanks News for BSX


News

Stocktwits